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would hypothetical disease-modifying
strategies that could reduce but
not eliminate PrPc expression benefit
neurologically impaired patients?
Absent such information, it is important
that methods including RNAi and PrP
antibody based approaches be devel-
oped and evaluated (Donofrio et al.,
2005; Enari et al., 2001; Golding
et al., 2006; Peretz et al., 2001; Pfeifer
et al., 2006; White et al., 2003). Testing
of candidate therapeutics in animal
models could determine the optimal
timing for administration (with respect
to disease stage), the capacity to
attenuate and/or reverse features of
disease, the impact of subject age on
efficacy, and whether they are effective
singly or in combination. It is hoped
that a successful demonstration of
a preclinical therapy of a prionosis
would enable early-stage clinical trials.
Moreover, the extension of this general
approach of defining a reversible
phase and enabling interventions to
the more common protein misfolding
diseases such as Alzheimer’s
and Parkinson’s should be strongly
encouraged.
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Calpain-mediated cleavage of neuronal targets has long been associated with excitotoxicity and
synaptic plasticity. In this issue of Neuron, two papers by Xu et al. and Abe and Takeichi explore
the respective roles of mGluR1a cleavage in excitotoxicity and b-catenin cleavage in transcriptional
control. Together, these papers show the functional importance of fragments of calpain-mediated
cleavage.Calpain, sometimes referred to as cal-
cium-activated neutral protease, is
among the most enigmatic proteases
in the body and particularly the nervous
system (Wu and Lynch, 2006). This
family of proteases is recognized by
their requirement for calcium and
defined by specific inhibitors, but theirsubstrate specificity defies complete
classification. Calpain cleaves at pre-
ferred sequences in association with
preferred tertiary structures of sub-
strates, but without known absolute
rules. Unlike most proteases, sub-
strates of calpain are not usually
destroyed but instead become dys-Neuron 53, Fregulated. Perhaps because of this un-
usual specificity, these enzymes have
been associated with a diverse set of
cellular functions inside and outside
the nervous system. In neurons, spec-
trin has been defined as the prototypic
substrate for calpain, inadvertently
promoting the idea that the mainebruary 1, 2007 ª2007 Elsevier Inc. 317
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PreviewsFigure 1. Calpain Activation and Cleavage of Multiple Targets
Ca2+ entry through NMDA receptors activates calpain, which then cleaves a variety of downstream
targets, including NMDA subunit NR2B, mGluR1a, and b-catenin. This cleavage dissociates
mGluR1a from the protective PI3K-Akt pathway. Cleaved b-catenin is no longer susceptible to
GSK-3b-mediated proteolysis and can translocate into the nucleus where it acts as a transcription
factor. Similarly, cleaved fragments of Ca2+ channel subunits can also act as transcription factors,
although it is unclear if this cleavage is mediated by calpain.function of calpain is structural modifi-
cation. However, calpain has been as-
sociated with a variety of other cellular
events, from cell adherence and cell
division to transcriptional regulation
and long-term potentiation (LTP).
While calpain is clearly involved in
these processes, the exact substrates
and mechanisms by which calpain
mediates its effects have been more
difficult to elucidate. In this issue of
Neuron, two articles link calpain-medi-
ated cleavage of specific substrates to
physiological and pathophysiological
events in the nervous system. The first
(Xu et al., 2007) investigates the known
association of calpain with NMDA-
receptor-mediated excitotoxicity. In
this work, they show that calpain-medi-
ated cleavage of mGluR1a creates
functional receptors that enhance
NMDA-induced excitotoxicity. More-
over, blocking calpain-mediated cleav-
age of mGluR1a with a fusion peptide
containing the calpain-sensitive por-
tion of the receptor protects neurons
from excitotoxicity in vitro and in vivo.
This deleterious effect of cleaved re-
ceptors may reflect their dissociation318 Neuron 53, February 1, 2007 ª2007from the neuroprotective PI3K-Akt
pathway, which in turn would enhance
toxicity arising from NMDA receptor
overstimulation. Such work thus pro-
vides a specific calpain-mediated
pathway contributing to early steps in
excitotoxicity, not simply the later
structural changes frequently attrib-
uted to calpain in excitotoxic models
(Wu and Lynch, 2006).
While the present work shows the
importance of this pathway, calpain
also probably regulates excitotoxicity
and PI3K through other substrates (Fig-
ure 1). The sodium/calcium exchanger
is cleaved by calpain in a manner lead-
ing to its destruction (Bano et al., 2005),
leaving neurons unable to handle the
calcium overload from NMDA receptor
activation. In addition, the NR2B sub-
unit of NR1/2B receptors is also a cal-
pain substrate in neurons (Simpkins
et al., 2003). Interestingly, it is cleaved
in a location that separates the channel
of the receptor from the residues in-
volved in NMDA-receptor-mediated
PI3K activation (Waxman and Lynch,
2005). Whether this is toxic (by loss of
PI3K activation) or protective (if PI3KElsevier Inc.were to become autonomously active)
is difficult to ascertain. Similarly, a vari-
ety of other synaptic substrates are
cleaved with a mixture of proposed
protective and toxic roles (Wu and
Lynch, 2006). Global inhibition of
calpain might thus be hard to utilize as
a potential therapeutic intervention in
the early phases of excitotoxicity. The
present study provides a paradigm for
interpreting the role of calpain-medi-
ated mGluR cleavage specifically in
excitotoxic therapy and a rationale for
developing substrate-selective ap-
proaches (such as the fusion protein
used here) for modulating calpain.
In contrast, the second work (Abe
and Takeichi, 2007) takes calpain
from a local mediator to a modulator
of defined signaling pathways control-
ling transcription. b-catenins are tran-
scriptional modulators involved in
variety of cellular events, including car-
cinogenesis and development. In the
present work, the authors demonstrate
that NMDA-receptor-activated calpain
cleaves b-catenins into stable frag-
ments in neurons. Such fragments
become resistant to GSK3b-mediated
proteolysis, undergo nuclear translo-
cation, and modulate transcription of
specific genes controlled by the tran-
scription factor Tcf. Furthermore, not
only is this pathway activated under
potentially excitotoxic conditions but
also in rats undergoing exploratory
behavior, linking calpain to genetic
control of neuronal plasticity. Though
not the first example of genetic regula-
tion based on calpain-mediated cleav-
age (IkBa and calcineurin also alter
transcription following calpain-medi-
ated cleavage) (Wu and Lynch, 2006;
Shumway et al., 1999), this paper pro-
vides further evidence that the calpain
system is not only a destructive system
but also an essential component of
ongoing activity in the nervous system.
How do these studies aid in the con-
ceptual understanding of the calpain
system and how it may be manipu-
lated? At first glance these results
provide further evidence of the diversity
of calpain substrates but no easy way
to conceptualize the role of calpain
based on substrate specificity. How-
ever, these papers provide consider-
able insight into the functional role of
Neuron
Previewscalpain-mediated proteolysis as a reg-
ulatory mechanism capable of signal-
ing in local fashion at synapses and
to nuclear targets. Future work in un-
derstanding the regulatory role of
calpain thus might concentrate not on
definition of targets alone but also reg-
ulation of these targets. For example,
the fusion protein controlling mGluR
cleavage appears to be selectively
directed to NMDA-receptor-activated
calpain at the synapse by mechanisms
that are not yet clear (Xu et al., 2007).
Two important concepts that emerge
as regulatory mechanisms involve
control of substrate specificity by
phosphorylation and of calpain activity
itself by the balance with its endoge-
nous inhibitor calpastatin (Wu and
Lynch, 2006; Cuevas et al., 2003;
Sawhney et al., 2006). In focal adhe-
sion, activity of calpain and its targeting
to specific substrates involves forma-
tion of a macromolecular complex
involving calpain, ERK, Src, and the
target integrins. Perhaps synapses
use similar mechanisms for directing
calpain to relevant substrates.
Finally, the present studies also raise
the question of whether other regula-Cortical Songs R
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Recordings from single neurons
events. These repeats are known
replay of spatiotemporal firing se
use compelling statistical analys
chains, such cortical motifs are b
fluctuations in neurons.
How do neurons encode information?
Donald Hebb suggested that the cor-
tex processes information throughtory proteases not yet discovered exist
in the nervous system. Although NR1 of
the NMDA receptor is not normally
a calpain substrate in neurons, some
studies have suggested that its C
terminus can undergo nuclear translo-
cation (Wu and Lynch, 2006; Bradley
et al., 2006). Similarly, the C termini of
various voltage-gated calcium chan-
nels can be cleaved and translocated
to the nucleus (Gomez-Ospina et al.,
2006; Kordasiewicz et al., 2006), where
they can act as transcription factors
(Gomez-Ospina et al., 2006). Such
a process may be involved in the path-
ogenesis of spinocerebellar ataxia type
6. While it is suspected that calpain
may be involved, direct evidence for a
role for calpain is lacking. Conse-
quently, the concept of proteolysis as
a regulatory rather than destructive
mechanism may exist even beyond
the calpain system.
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